Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

The Joint Corp (NQ: JYNT )

12.65 -0.14 (-1.09%)
Streaming Delayed Price Updated: 12:01 PM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about The Joint Corp

< Previous 1 2 3 Next >
Dow Gains Over 100 Points; AerSale Shares Plunge After Q4 Results
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dipping around 0.5% on Friday. The Dow traded up 0.27% to 38,894.21 while the NASDAQ fell 0.51% to 16,190.52. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance. 
Via Benzinga
Recap: Joint Q3 Earnings
Via Benzinga
Recap: Joint Q1 Earnings
Via Benzinga
4 Analysts Have This to Say About Joint
Joint (NASDAQ:JYNT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
JYNT Stock Earnings: Joint Misses EPS, Beats Revenue for Q4 2023
JYNT stock results show that Joint missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results. 
Via Benzinga
Earnings Scheduled For March 7, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
Joint Corp: From Growth To Deep Value
The Joint Corporation is the largest domestic franchisor and operator of chiropractic clinics. 
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
$3M Bet On Tidewater? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades. 
Via Benzinga
Dow Surges 100 Points; US Consumer Sentiment Tops Expectations
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 100 points on Friday. The Dow traded up 0.30% to 35,280.26 while the NASDAQ fell 0.48% to 13,672.51. The S&P 500, also... 
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
Via Benzinga
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Nasdaq Down 100 Points; Wholesale Prices Rise More Than Expected
U.S. stocks traded lower this morning, following the release of PPI data on Friday. Following the market opening Friday, the Dow traded down 0.16% to 35,121.51 while the NASDAQ fell 0.84% to 13,622.68.... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Insiders Buying Joint Corp And 2 Other Stocks
Although US stocks closed higher on Tuesday, there were a few notable insider trades. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
Via Benzinga
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
Moderna To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday
Morgan Stanley raised the price target for NIKE, Inc. (NYSE: NKE) from $138 to $140. Morgan Stanley analyst Alexandra Steiger maintained an Overweight rating. NIKE shares fell 0.1% to $117.45 in... 
Via Benzinga
$1.4 Million Bet On Joint Corp? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed lower on Tuesday, there were a few notable insider trades. 
Via Benzinga
Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on Thursday. 
Via Benzinga
Earnings Preview For Joint
Joint (NASDAQ:JYNT) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Joint will report an... 
Via Benzinga
$12.2 Million Bet On WESCO International? 3 Stocks Insiders Are Buying
Although US stocks closed lower on Thursday, there were a few notable insider trades. 
Via Benzinga
$3.8 Million Bet On This Technology Stock? 3 Stocks Insiders Are Buying
Although US stocks traded mostly lower on Tuesday, there were a few notable insider trades. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
  
Via Benzinga
Recap: Joint Q2 Earnings
Joint (NASDAQ:JYNT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Joint beat estimated earnings by... 
Via Benzinga
Preview: Joint's Earnings
Joint (NASDAQ:JYNT) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Joint will report an... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.